Third Harmonic Bio Inc.

NASDAQ THRD

Data sourced from

and

Daily

Download Data

Third Harmonic Bio Inc. Market Capitalization on June 03, 2024: USD 555.68 M

Third Harmonic Bio Inc. Market Capitalization is USD 555.68 M on June 03, 2024, a 191.02% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.

Third Harmonic Bio Inc. 52-week high Market Capitalization is USD 636.35 M on May 21, 2024, which is 14.52% above the current Market Capitalization.
Third Harmonic Bio Inc. 52-week low Market Capitalization is USD 190.95 M on June 05, 2023, which is -65.64% below the current Market Capitalization.
Third Harmonic Bio Inc. average Market Capitalization for the last 52 weeks is USD 336.63 M.

NASDAQ: THRD

Third Harmonic Bio Inc.

CEO	Ms. Natalie C. Holles
IPO Date	Sept. 14, 2022
Location	United States
Headquarters	300 Technology Square, Cambridge, MA, United States, 02139
Employees	31
Sector	Healthcare
Industry	Biotechnology

Description

Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases. The company develops oral small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It is also developing THB335, an oral small molecule KIT inhibitor for the treatment of mast cell-mediated skin, respiratory, and gastrointestinal conditions. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in San Francisco, California.

Key trends